The Aperlena Verdict
Open raceNo supplier dominates: 17 different companies have won the last 22 comparable contracts from this buyer over 5 years. This is a genuinely open race.
Based on 22 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThe buyer is procuring a batch of medicines, mainly infusion and injection solutions. The list includes sodium chloride 0.9% infusion solution in 200 ml and 100 ml bottles, dexamethasone phosphate 4 mg/ml ampoules, sodium sulfacetamide 30% eye drops, suprastin injection, euphyllin, asparkam, adrenaline 0.18% and 40% glucose solution, in specified package quantities. Goods must not originate from Russia, Belarus or Iran. Quality must be confirmed by certificates and sanitary-epidemiological expertise. Remaining shelf life at delivery must be at least 80% of total shelf life. Payment is made within 7 banking days after delivery. Transport and related costs are borne by the supplier. Storage without refrigeration except sodium sulfacetamide.
Description
Official source
Source: ProZorro - Public e-procurement of Ukraine
Always verify details on the official notice.
Last verified against ProZorro - Public e-procurement of Ukraine 9 hours ago
More from this buyer
Full buyer profileRecent awards
Similar tenders
1
day left
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €8,668,376
- Buyer track record on Aperlena
- 28 notices tracked · 23 awarded
Never miss a tender like this
Get an email for new tenders matching: Medical equipment & pharmaceuticals · Ukraine. Free.
Set up my alert